Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy
Philip D. Dunne
,
Darragh G. McArt
,
Paul G. O’Reilly
,
Philip D. Dunne
,
Darragh G. McArt
,
Paul G. O’Reilly
,
Helen G. Coleman
,
Wendy L. Allen
,
Maurice B. Loughrey
,
Sandra Van Schaeybroeck
,
Simon S. McDade
,
Manuel Salto‐Tellez
,
Daniel B. Longley
,
Mark Lawler
,
Patrick G. Johnston
2016
Cancer Immunology Research
40 citations